The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

A study from the University of Birmingham, UK, has indicated that the use of digoxin could lead to substantial cost savings for the National Health Service (NHS) when treating senior individuals with ...

Digoxin 0.05mg; per mL; lime-flavored; contains alcohol 10%. Renal dysfunction: reduce dose. Sinus node disease. Incomplete AV block. Accessory AV pathway (Wolff-Parkinson-White syndrome).

Digoxin toxicity is a life-threatening condition. The most common symptoms are gastrointestinal and include nausea, vomiting, abdominal pain and diarrhea. The cardiac manifestations are concerning ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

The team reported on the study results in Nature Medicine, in a paper titled, “Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial ...

In a clinical study, the researchers administered the drug digoxin at a low and safe dosage for one week to nine patients with metastatic breast cancer. The result: the number of cells per cluster ...

Heart failure (HF) is the leading cause of hospitalization among older adults. Digoxin has been shown to reduce hospitalization due to worsening HF. However, at the commonly prescribed dose of 0. ...

Digoxin blocks these ion pumps and thus suppresses the ion exchange. The cells therefore absorb more calcium from the outside of the cell membrane. This weakens the cohesion of the cancer cells in ...

First used in 1785, this century-old medication is now emerging as a modern solution with significant healthcare benefits ...

When the heart skips a beat: research from discovery science through to benefits for patients and the NHS. Throughout the ...

Digoxin, originally derived from the foxglove flower, blocks the sodium/potassium ATPase pump. The mechanism by which this decreases atrioventricular (AV) conduction is not clear, butperhaps it is ...